Philipp Nicol

Dr. Philipp Nicol


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 February 2020 in Molecules
Verified
Journal Article
Open access
PDF file
TLTobias Lenz
Tobias Lenz
PNPhilipp Nicol
Philipp Nicol
MCMaria Isabel Castellanos
Maria Isabel Castellanos
LELeif-Christopher Engel
Leif-Christopher Engel
ALAnna Lena Lahmann
Anna Lena Lahmann
MJMichael Joner
Michael Joner
Extensive translational research has provided considerable progress regarding the understanding of atherosclerosis pathophysiology over the last decades. In contrast, implementation of molecular in vivo imaging remains highly limited. In that context, nanoparticles represent a useful tool. Their variable shape and composition assure biocompatibility and stability within the environment of intended use, while the possibility of conjugating different ligands as well as contrast dyes enable targeting of moieties of interest on a molecular level and visualization throughout various imaging modalities. These characteristics have been exploited by a number of preclinical research approaches aimed at advancing understanding of vascular atherosclerotic disease, in order to improve identification of high-risk lesions prior to oftentimes fatal thromboembolic events. Furthermore, the combination of these targeted nanoparticles with therapeutic agents offers the potential of site-targeted drug delivery with minimized systemic secondary effects. This review gives an overview of different groups of targeted nanoparticles, designed for in vivo molecular imaging of atherosclerosis as well as an outlook on potential combined diagnostic and therapeutic applications.

31 March 2025 in The International Journal of Cardiovascular Imaging
Verified
Journal Article
Open access
PDF file
FSFinn Syryca
Finn Syryca
CGChristian Gräßer
Christian Gräßer
TTTeresa Trenkwalder
Teresa Trenkwalder
PNPhilipp Nicol
Philipp Nicol
Accurate interpretation of echocardiography measurements is essential for diagnosing cardiovascular diseases and guiding clinical management. The emergence of large language models (LLMs) like ChatGPT presents a novel opportunity to automate the generation of echocardiography reports and provide clinical recommendations. This study aimed to evaluate the ability of an LLM (ChatGPT) to 1) generate comprehensive echocardiography reports based solely on provided echocardiographic measurements, and when enriched with clinical information 2) formulate accurate diagnoses, along with appropriate recommendations for further tests, treatment, and follow-up. Echocardiographic data from n = 13 fictional cases (Group 1) and n = 8 clinical cases (Group 2) were input into the LLM. The model’s outputs were compared against standard clinical assessments conducted by experienced cardiologists. Using a dedicated scoring system, the LLM’s performance was evaluated and stratified based on its accuracy in report generation, diagnostic precision, and the appropriateness of its recommendations. Patterns, frequency and examples of misinterpretations by LLM were analysed. Across all cases, mean total score was 6.86 (SD = 1.12). Group 1 had a mean total score of 6.54 (SD = 1.13) and accuracy of 3.92 (SD = 0.86), while Group 2 scored 7.38 (SD = 0.92) and 4.38 (SD = 0.92), respectively. Recommendations were 2.62 (SD = 0.51) for Group 1 and 3.00 (SD = 0.00) for Group 2, with no significant differences (p = 0.096). Fully acceptable reports were 85.7%, borderline acceptable 14.3%, and none were not acceptable. Of 299 parameters, 5.3% were misinterpreted. The LLM demonstrated a high level of accuracy in generating detailed echocardiography reports, mostly correctly identifying normal and abnormal findings, and making accurate diagnoses across a range of cardiovascular conditions. ChatGPT, as an LLM, shows significant potential in automating the interpretation of echocardiographic data, offering accurate diagnostic insights and clinical recommendations. These findings suggest that LLMs could serve as valuable tools in clinical practice, assisting and streamlining clinical workflow. Graphical abstract

1 January 2015 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
FWFlorian Weinberger
Florian Weinberger
DMDennis Mehrkens
Dennis Mehrkens
JSJutta Starbatty
Jutta Starbatty
PNPhilipp Nicol
Philipp Nicol
TEThomas Eschenhagen
Thomas Eschenhagen

22 February 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
LELeif-Christopher Engel
Leif-Christopher Engel
RARafael Adolf
Rafael Adolf
SCSalvatore Cassese
Salvatore Cassese
EXErion Xhepa
Erion Xhepa
AKAdnan Kastrati
Adnan Kastrati
PNPhilipp Nicol
Philipp Nicol
Background: Perivascular fat attenuation index (FAI) derived from coronary CT angiography (CCTA) has emerged as a quantitative biomarker of vascular inflammation, with potential to improve risk stratification in coronary artery disease (CAD) patients. This study aimed to evaluate plaque characteristics of coronary atherosclerotic lesions in patients with high (≥−70.1 HU) or low FAI of pericoronary adipose tissue. Methods: In a retrospective analysis, patients with suspected or confirmed CAD who underwent coronary CTA were included. Coronary lesions were classified into two groups based on their perivascular inflammation as assessed by CCTA: high perivascular FAI phenotype (≥−70.1 HU) versus low FAI phenotype (<−70.1 HU). Both groups were compared with respect to various patient- and lesion-specific characteristics. Results: A total of 247 coronary lesions were analyzed in this study. Of these, 36 (14.6%) lesions were associated with high perivascular inflammation (high FAI phenotpye) and 211 (85.4%) were associated with low perivascular inflammation (low FAI phenotype). Lesions with a high FAI phenotype demonstrated a significantly higher amount of non-calcified plaque volume (NCPV) compared to lesions with a low FAI phenotype [(111.8 mm3 (69.4–184.2) versus 87.7 mm3 (44.6–143.0), p < 0.003]. NCPV emerged as a consistent and significant predictor of fat attenuation positive plaque in both univariate (OR 1.030 [95% CI, 1.010–1.050], p = 0.003); and multivariate logistic regression analyses (OR 1.028 [95% CI, 1.008–1.050]. p = 0.007). Additionally, lesions with a high FAI phenotype less frequently exhibited homogeneous calcification than their low FAI phenotype counterparts (25% versus 46.9%, p = 0.014). Conclusions: Coronary lesions associated with a high FAI phenotype on coronary CCTA consist predominantly of non-calcified plaques. Conversely, lesions characterized by a low perivascular FAI phenotype are primarily calcified and seem to be more homogeneous by visual assessment. Further prospective studies are warranted to validate these associations and explore the underlying pathophysiological mechanisms.

19 January 2026 in IJC Heart & Vasculature
Verified
Journal Article
Open access
PNPhilipp Nicol
Philipp Nicol
RARafael Adolf
Rafael Adolf
SCSalvatore Cassese
Salvatore Cassese
AKAdnan Kastrati
Adnan Kastrati
MJMichael Joner
Michael Joner
LELeif-Christopher Engel
Leif-Christopher Engel
Coronary artery calcium (CAC) scoring is an established marker of atherosclerotic burden and cardiovascular risk. While the Agatston score is the clinical gold standard, alternative visual scoring methods—including the Visual Ordinal Score, Weston Score, and Vessel-specific extent-based score—are increasingly used, particularly in non-gated or opportunistic CT imaging. This study aimed to compare the diagnostic performance, inter-observer reliability, and correlation of different visual scoring methods against the Agatston score. A total of 299 cases were evaluated using ECG-gated CT scans. Each case was independently scored in a blinded fashion by two observers using three visual methods: (1) Visual Ordinal Score (VS), (2) Weston Score (WS) and (3) Vessel-specific extent-based score (VSES). A novel visual CAC score was derived by combining Weston and Vessel-specific extent-based scoring (= Weston Extent Score, WES). Cohen’s Kappa and Intraclass Correlation Coefficients (ICC) were used for inter-observer agreement. Classification performance was assessed against Agatston-based categories (No CAC, Mild, Moderate, Severe), including accuracy, precision, sensitivity, and specificity. Correlation analyses were conducted using Pearson and Spearman coefficients. All scoring methods showed high correlation with the Agatston score (Spearman ρ > 0.87; p < 0.001). Visual scoring demonstrated the highest inter-observer agreement (Kappa = 0.94, ICC = 0.97), followed by Weston (Kappa = 0.90) and Vessel-Specific scores (Kappa = 0.77). Visual scoring also yielded the highest accuracy (Observer 1: 91.3 %, Observer 2: 90.0 %) The newly derived WES score achieved 80.9 % accuracy, with macro-averaged specificity of 93.8 % and improving diagnostic accuracy compared to WS and VSES. Different visual scoring offers excellent reproducibility and diagnostic accuracy for CAC classification, with strong correlation to the Agatston score. The newly-derived WES score could be useful in providing a practical balance regarding volumetric information (CAC densitiy) and anatomical distribution of CAC. These findings support the implementation of structured visual CAC scoring in clinical and opportunistic CT settings.